Hinge Health, Inc. (HNGE) Price Target Analysis
Updated Jul 2, 2026
Analyst Rating: Buy
Based on 16 analysts13.6% Above Target
HNGE trades 13.6% above Wall Street's consensus target of $77.17.
Current Price$89.30
Average Target$77.17
Target
Current
Low$45.00
Median$77.50
High$95.00
Analyst Target Range
Forward P/E34.4x
(Growth Premium)
PEG Ratio—
Implied Growth+141.9%
(High Growth)
Analyst Spread64.8%
(Wide Disagreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes HNGE achieves its forward estimates and maintains a stable P/E multiple of 34.4x. This scenario reflects the blended consensus of 16 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
HNGE Price Target Analysis
Updated July 8, 2026As of July 8, 2026, Hinge Health, Inc. (HNGE) has a Wall Street consensus price target of $77.17, based on estimates from 16 covering analysts. With the stock currently trading at $89.30, this represents a potential downside of -13.6%. The company has a market capitalization of $7.03B.
Analyst price targets range from a low of $45.00 to a high of $95.00, representing a 65% spread in expectations. The median target of $77.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 15 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HNGE trades at a trailing P/E of -17.2x and forward P/E of 34.4x. Analysts expect EPS to grow +141.9% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+7.5%
Industry Consensus
Avg Forward P/E
18.9x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 OMCLOmnicell, Inc. | $2.0B | $44.36 | $57.20 | +28.9% | Hold | 22.9x | 19 |
 TDOCTeladoc Health, Inc. | $1.6B | $9.10 | $7.40 | -18.7% | Hold | — | 42 |
 HIMSHims & Hers Health, Inc. | $7.9B | $36.17 | $28.69 | -20.7% | Hold | — | 20 |
 DOCSDoximity, Inc. | $4.3B | $22.74 | $29.47 | +29.6% | Hold | 15.9x | 23 |
 AMWLAmerican Well Corporation | $150M | $8.99 | $6.33 | -29.6% | Hold | — | 15 |
 OPRXOptimizeRx Corporation | $118M | $6.29 | $10.50 | +66.9% | Buy | 6.7x | 15 |
 TALKTalkspace, Inc. | $871M | $5.20 | $5.25 | +1.0% | Hold | 40.2x | 10 |
 UNHUnitedHealth Group Incorporated | $388.9B | $428.19 | $426.75 | -0.3% | Buy | 23.3x | 52 |
 CVSCVS Health Corporation | $133.1B | $104.33 | $103.64 | -0.7% | Buy | 14.1x | 41 |
 CICigna Corporation | $75.6B | $286.62 | $340.91 | +18.9% | Buy | 9.4x | 39 |
HNGE — Frequently Asked Questions
Quick answers to the most common questions about buying HNGE stock.
What is the HNGE stock price target for 2026?
HNGE's consensus price target is $77.17, -13.6% below the current price of $89.3. The 16 analysts tracking HNGE see downside risk at present valuations.
Is HNGE a buy, sell, or hold?
HNGE has a consensus rating of "Buy" based on 16 Wall Street analysts. The rating breakdown is predominantly bullish, with 15 Buy/Strong Buy ratings. The consensus 12-month price target of $77.17 implies -13.6% downside from current levels.
Is HNGE stock overvalued or undervalued?
HNGE trades at a forward P/E of 34.4402x, representing a moderate valuation. With analysts targeting $77.17 (-13.6% implied move), the stock appears close to fair value.
How high can HNGE stock go?
The most bullish Wall Street analyst has a price target of $95 for HNGE, while the most conservative target is $45. The consensus of $77.17 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover HNGE stock?
HNGE is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the HNGE stock forecast?
The 12-month HNGE stock forecast based on 16 Wall Street analysts shows a consensus price target of $77.17, with estimates ranging from $45 (bear case) to $95 (bull case). The median consensus rating is "Buy".
What is HNGE's forward P/E ratio?
HNGE trades at a forward P/E ratio of 34.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy HNGE stock?
Analysts are cautious on HNGE, with 0 Sell ratings and a price target of $77.17 (-13.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do HNGE price targets vary so much?
HNGE analyst price targets range from $45 to $95, a 65% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $77.17 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare